Pavion Blue Capital’s Clorox CLX Stock Holding History

Pavion Blue Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,950	Closed	-$202K	–	113
2026 Q1	$202K	Sell	1,950 -300	-13%	-$34K	0.09%	107
2025 Q4	$227K	Hold	2,250	–	–	0.09%	97
2025 Q3	$277K	Hold	2,250	–	–	0.12%	84
2025 Q2	$270K	Buy	2,250 +300	+15%	+$40K	0.12%	84
2025 Q1	$287K	Hold	1,950	–	–	0.14%	78
2024 Q4	$317K	Hold	1,950	–	–	0.15%	75
2024 Q3	$318K	Sell	1,950 -290	-13%	-$43K	0.15%	76
2024 Q2	$306K	Sell	2,240 -160	-7%	-$22.2K	0.15%	75
2024 Q1	$367K	Hold	2,400	–	–	0.18%	72
2023 Q4	$342K	Hold	2,400	–	–	0.19%	70
2023 Q3	$315K	Hold	2,400	–	–	0.19%	71
2023 Q2	$382K	Hold	2,400	–	–	0.22%	68
2023 Q1	$380K	Hold	2,400	–	–	0.23%	69
2022 Q4	$337K	Hold	2,400	–	–	0.21%	70
2022 Q3	$308K	Sell	2,400 -69	-3%	-$9.96K	0.22%	67
2022 Q2	$348K	Hold	2,469	–	–	0.23%	64
2022 Q1	$343K	Hold	2,469	–	–	0.2%	66
2021 Q4	$430K	Hold	2,469	–	–	0.25%	59
2021 Q3	$409K	Hold	2,469	–	–	0.25%	60
2021 Q2	$444K	Hold	2,469	–	–	0.27%	59
2021 Q1	$476K	Hold	2,469	–	–	0.31%	55
2020 Q4	$499K	Hold	2,469	–	–	0.34%	56
2020 Q3	$519K	Hold	2,469	–	–	0.4%	56
2020 Q2	$542K	Hold	2,469	–	–	0.47%	50
2020 Q1	$428K	Buy	+2,469	New	+$408K	0.44%	51

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Pavion Blue Capital's CLX Position: Q2 2026 in Review

Pavion Blue Capital sold out of Clorox (CLX) in Q2 2026, closing a stake of 1,950 shares — an estimated $202K sold.

Pavion Blue Capital first reported a position in CLX in Q1 2020 and held it in 25 quarters. The position peaked at $542K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Pavion Blue Capital reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
Pavion Blue Capital sold 1,950 Clorox shares in Q2 2026, an estimated $202K.
Pavion Blue Capital first reported a position in Clorox in Q1 2020 and held it in 25 quarters.
Pavion Blue Capital's Clorox position peaked at $542K in Q2 2020.
1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Pavion Blue Capital's 13F filing for Q2 2026, filed 7 Aug 2026.